COMP <GO>
RDNT vs LLY // ENTERPRISE SCALE & MARKET CAP
RadNet Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: RDNT 1
— LLY 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: LLY
LAST: $73.49 (-0.22%) • MKT CAP: $5.78B
market-cap
$5.78B
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
market-cap
$1.33T
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDNT VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDNT | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 83.64% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.50% | 32.36% | -28.86 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 98.3x | 36.4x | +61.91 | LLY | /valuation <GO> |
| Free Cash Flow Yield | 5.16% | 2.30% | +2.86 | RDNT | /fcf-yield <GO> |
| Operating Margin | 3.00% | 40.21% | -37.21 | LLY | /operating-margins <GO> |
| Net Profit Margin | -0.90% | 31.90% | -32.80 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 45.51% | -34.01 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.15 | 9.29 | -7.14 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.81% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.9 | 71.0 | -13.10 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 30.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.78B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDNT REV | LLY REV | RDNT GROSS % | LLY GROSS % | RDNT FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.04B | $65.18B | — | 83.0% | $298.8M | $16.81B |
| FY 2024 | $1.83B | $45.04B | — | 81.3% | $233.0M | $8.82B |
| FY 2023 | $1.62B | $34.12B | — | 79.3% | $220.9M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDNT // BETA —
LLY // BETA 0.51